Neuropulsas - Company finances
|
EUR
|
2024
From: 2024-06-25
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|
|
Financial data
|
||
| Sales revenue | 5,616 | 132,781 |
| Profit before tax | -19,444 | -149,424 |
| Net profit | -19,444 | -149,424 |
| Equity | -18,444 | -157,268 |
| Liabilities | 57,476 | 250,600 |
| Non-current assets | 0 | 55,275 |
| Current assets | 39,032 | 37,229 |
| Total assets | 39,032 | 92,504 |
|
Taxes paid
|
||
| STI taxes | 249 | 21,172 |
| Social insurance contributions | - | 25,085 |
|
Financial indicators
|
||
| Revenue change y/y | - | +2264.3% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -49.8% | -161.5% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | - | - |
| Profit margin Net profit margin. Shows the overall profitability of the company. | -346.2% | -112.5% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | -346.2% | -112.5% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 5,616 | 11,546 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Neuropulsas - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2025-05-04 | 2025-05-05 | 1.96 |
| 2025-04-24 | 2025-04-29 | 1.96 |
| 2025-03-18 | 2025-03-30 | 330.43 |
Neuropulsas - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-07-01 | 2026-07-26 | 0.02 |
| 2026-06-28 | 2026-06-29 | 45.0 |
| 2026-06-01 | 2026-06-05 | 0.04 |
| 2026-05-01 | 2026-05-31 | 0.02 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Neuropulsas, UAB (code 306879348) is a Private Limited Liability Company engaged in medical specialists activities. In 2025, the company generated revenue of €132.8K, up sharply from €5.6K in 2024, reflecting a much larger operating scale over a full 364-day period compared with 189 days in the prior year. Despite the stronger turnover, profitability remained negative: net loss widened to €149.4K in 2025 from €19.4K in 2024, and the profit margin stayed below zero at -112.5%. The balance sheet at year-end 2025 showed total assets of €92.5K, including €55.3K in long-term assets and €37.2K in short-term assets. Equity was negative at -€157.3K, while liabilities amounted to €250.6K, indicating a leveraged capital structure. Asset turnover was 1.44x, showing revenue generation relative to the asset base, while revenue per employee was €12.1K and profit per employee was -€13.6K. Overall, 2025 was a year of rapid revenue growth, but losses and negative equity remained significant.